Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised

Naosuke Yokomichi, Tatsuya Morita, Akihiro Nitto, Naoko Takahashi, Shingo Miyamoto, Hiroyuki Nishie, Junji Matsuoka, Hiroki Sakurai, Tatsuhiko Ishihara, Masanori Mori, Yoko Tarumi, Asao Ogawa

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.

Original languageEnglish
Pages (from-to)718-723
Number of pages6
JournalJournal of Pain and Symptom Management
Volume50
Issue number5
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Symptom Assessment
Neoplasms
Reproducibility of Results
Quality of Life
Organizations
Equipment and Supplies
Research
Therapeutics

Keywords

  • Edmonton Symptom Assessment System
  • Edmonton Symptom Assessment System-revised
  • reliability
  • symptom assessment
  • validation
  • validity

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Nursing(all)

Cite this

Yokomichi, N., Morita, T., Nitto, A., Takahashi, N., Miyamoto, S., Nishie, H., ... Ogawa, A. (2015). Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised. Journal of Pain and Symptom Management, 50(5), 718-723. https://doi.org/10.1016/j.jpainsymman.2015.05.014

Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised. / Yokomichi, Naosuke; Morita, Tatsuya; Nitto, Akihiro; Takahashi, Naoko; Miyamoto, Shingo; Nishie, Hiroyuki; Matsuoka, Junji; Sakurai, Hiroki; Ishihara, Tatsuhiko; Mori, Masanori; Tarumi, Yoko; Ogawa, Asao.

In: Journal of Pain and Symptom Management, Vol. 50, No. 5, 01.11.2015, p. 718-723.

Research output: Contribution to journalArticle

Yokomichi, N, Morita, T, Nitto, A, Takahashi, N, Miyamoto, S, Nishie, H, Matsuoka, J, Sakurai, H, Ishihara, T, Mori, M, Tarumi, Y & Ogawa, A 2015, 'Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised', Journal of Pain and Symptom Management, vol. 50, no. 5, pp. 718-723. https://doi.org/10.1016/j.jpainsymman.2015.05.014
Yokomichi, Naosuke ; Morita, Tatsuya ; Nitto, Akihiro ; Takahashi, Naoko ; Miyamoto, Shingo ; Nishie, Hiroyuki ; Matsuoka, Junji ; Sakurai, Hiroki ; Ishihara, Tatsuhiko ; Mori, Masanori ; Tarumi, Yoko ; Ogawa, Asao. / Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised. In: Journal of Pain and Symptom Management. 2015 ; Vol. 50, No. 5. pp. 718-723.
@article{c9f97de89da74320976639b3570d6eac,
title = "Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised",
abstract = "Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.",
keywords = "Edmonton Symptom Assessment System, Edmonton Symptom Assessment System-revised, reliability, symptom assessment, validation, validity",
author = "Naosuke Yokomichi and Tatsuya Morita and Akihiro Nitto and Naoko Takahashi and Shingo Miyamoto and Hiroyuki Nishie and Junji Matsuoka and Hiroki Sakurai and Tatsuhiko Ishihara and Masanori Mori and Yoko Tarumi and Asao Ogawa",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jpainsymman.2015.05.014",
language = "English",
volume = "50",
pages = "718--723",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised

AU - Yokomichi, Naosuke

AU - Morita, Tatsuya

AU - Nitto, Akihiro

AU - Takahashi, Naoko

AU - Miyamoto, Shingo

AU - Nishie, Hiroyuki

AU - Matsuoka, Junji

AU - Sakurai, Hiroki

AU - Ishihara, Tatsuhiko

AU - Mori, Masanori

AU - Tarumi, Yoko

AU - Ogawa, Asao

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.

AB - Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.

KW - Edmonton Symptom Assessment System

KW - Edmonton Symptom Assessment System-revised

KW - reliability

KW - symptom assessment

KW - validation

KW - validity

UR - http://www.scopus.com/inward/record.url?scp=84945449320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945449320&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2015.05.014

DO - 10.1016/j.jpainsymman.2015.05.014

M3 - Article

C2 - 26169339

AN - SCOPUS:84945449320

VL - 50

SP - 718

EP - 723

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 5

ER -